Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Bradley L Campbell. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Bradley L Campbell har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:FOLD / Amicus Therapeutics, Inc. | President and CEO, Director | 1 137 282 |
US:PGNX / Progenics Pharmaceuticals, Inc. | Director | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Bradley L Campbell. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp FOLD / Amicus Therapeutics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i FOLD / Amicus Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i FOLD / Amicus Therapeutics, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Bradley L Campbell som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-18 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −13 375 | 1 137 282 | −1,16 | 8,90 | −119 038 | 10 121 810 | |
2025-02-21 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −400 | 1 150 657 | −0,03 | 10,00 | −4 000 | 11 506 570 | |
2025-02-21 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 400 | 1 151 057 | 0,03 | 9,03 | 3 612 | 10 394 045 | |
2025-02-13 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −70 711 | 1 150 657 | −5,79 | 9,57 | −676 704 | 11 011 787 | |
2025-02-13 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 137 075 | 1 220 768 | 12,65 | ||||
2025-01-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −7 368 | 1 083 693 | −0,68 | 9,41 | −69 333 | 10 197 551 | |
2025-01-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −41 474 | 1 091 061 | −3,66 | 9,41 | −390 270 | 10 266 884 | |
2025-01-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 266 528 | 1 132 535 | 30,78 | ||||
2025-01-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −20 647 | 866 007 | −2,33 | 9,31 | −192 224 | 8 062 525 | |
2024-12-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −7 500 | 886 654 | −0,84 | 10,02 | −75 124 | 8 881 258 | |
2024-12-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 500 | 894 154 | 0,85 | 8,61 | 64 575 | 7 698 666 | |
2024-11-07 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −7 901 | 886 654 | −0,88 | 12,50 | −98 800 | 11 087 431 | |
2024-11-07 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 901 | 894 555 | 0,89 | 12,28 | 97 024 | 10 985 135 | |
2024-11-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −7 500 | 886 654 | −0,84 | 11,46 | −85 960 | 10 162 207 | |
2024-11-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 500 | 894 154 | 0,85 | 8,61 | 64 575 | 7 698 666 | |
2024-10-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −7 500 | 886 654 | −0,84 | 10,60 | −79 492 | 9 397 646 | |
2024-10-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 500 | 894 154 | 0,85 | 8,61 | 64 575 | 7 698 666 | |
2024-09-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −7 500 | 886 654 | −0,84 | 11,71 | −87 798 | 10 379 526 | |
2024-09-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 500 | 894 154 | 0,85 | 8,61 | 64 575 | 7 698 666 | |
2024-08-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −7 500 | 886 654 | −0,84 | 10,34 | −77 518 | 9 164 278 | |
2024-08-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 500 | 894 154 | 0,85 | 8,61 | 64 575 | 7 698 666 | |
2024-07-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −6 100 | 886 654 | −0,68 | 10,00 | −61 029 | 8 870 796 | |
2024-07-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 6 100 | 892 754 | 0,69 | 8,61 | 52 521 | 7 686 612 | |
2024-07-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 400 | 886 654 | −0,16 | 10,00 | −14 003 | 8 868 402 | |
2024-07-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 1 400 | 888 054 | 0,16 | 8,61 | 12 054 | 7 646 145 | |
2024-06-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −7 500 | 886 654 | −0,84 | 10,00 | −75 000 | 8 866 540 | |
2024-06-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 500 | 894 154 | 0,85 | 8,61 | 64 575 | 7 698 666 | |
2024-05-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −7 500 | 886 654 | −0,84 | 10,07 | −75 524 | 8 928 428 | |
2024-05-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 500 | 894 154 | 0,85 | 8,61 | 64 575 | 7 698 666 | |
2024-04-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −7 500 | 886 654 | −0,84 | 11,67 | −87 496 | 10 343 794 | |
2024-04-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 500 | 894 154 | 0,85 | 8,61 | 64 575 | 7 698 666 | |
2024-03-19 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −13 375 | 886 654 | −1,49 | 11,48 | −153 545 | 10 178 788 | |
2024-03-15 |
|
4/A | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −23 577 | 904 196 | −2,54 | 13,65 | −321 826 | 12 342 275 | |
2024-03-15 |
|
4/A | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 28 810 | 927 773 | 3,20 | ||||
2024-03-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −15 833 | 871 219 | −1,78 | 13,14 | −208 017 | 11 446 249 | |
2024-03-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 8 333 | 887 052 | 0,95 | 12,28 | 102 329 | 10 892 999 | |
2024-03-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 500 | 878 719 | 0,86 | 8,61 | 64 575 | 7 565 771 | |
2024-02-20 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −4 167 | 871 219 | −0,48 | 14,00 | −58 338 | 12 197 066 | |
2024-02-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −15 833 | 875 386 | −1,78 | 12,56 | −198 858 | 10 994 586 | |
2024-02-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 8 333 | 891 219 | 0,94 | 12,28 | 102 329 | 10 944 169 | |
2024-02-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 500 | 882 886 | 0,86 | 8,61 | 64 575 | 7 601 648 | |
2024-01-11 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −23 577 | 875 386 | −2,62 | 13,65 | −321 826 | 11 949 019 | |
2024-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −7 368 | 898 963 | −0,81 | 13,44 | −99 026 | 12 082 063 | |
2024-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −41 474 | 906 331 | −4,38 | 13,53 | −561 143 | 12 262 658 | |
2024-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −8 333 | 947 805 | −0,87 | 14,23 | −118 611 | 13 490 962 | |
2024-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 8 333 | 956 138 | 0,88 | 12,28 | 102 329 | 11 741 375 | |
2024-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −7 500 | 947 805 | −0,79 | 14,24 | −106 768 | 13 492 762 | |
2024-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 500 | 955 305 | 0,79 | 8,61 | 64 575 | 8 225 176 | |
2024-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −15 452 | 947 805 | −1,60 | 14,24 | −220 036 | 13 496 743 | |
2024-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 153 810 | 963 257 | 19,00 | ||||
2023-12-19 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 17 286 | 809 447 | 2,18 | ||||
2023-12-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −11 702 | 792 161 | −1,46 | 11,08 | −129 693 | 8 779 520 | |
2023-12-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 11 702 | 803 863 | 1,48 | 2,94 | 34 404 | 2 363 357 | |
2023-11-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −11 700 | 792 161 | −1,46 | 10,97 | −128 391 | 8 692 858 | |
2023-11-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 11 700 | 803 861 | 1,48 | 2,94 | 34 398 | 2 363 351 | |
2023-10-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −500 | 792 161 | −0,06 | 12,04 | −6 019 | 9 536 034 | |
2023-10-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −11 200 | 792 661 | −1,39 | 11,20 | −125 470 | 8 879 943 | |
2023-10-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 11 700 | 803 861 | 1,48 | 2,94 | 34 398 | 2 363 351 | |
2023-09-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −18 093 | 792 161 | −2,23 | 12,97 | −234 648 | 10 273 536 | |
2023-09-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 11 700 | 810 254 | 1,47 | 2,94 | 34 398 | 2 382 147 | |
2023-08-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −20 000 | 798 554 | −2,44 | 13,39 | −267 874 | 10 695 593 | |
2023-08-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 11 700 | 818 554 | 1,45 | 2,94 | 34 398 | 2 406 549 | |
2023-07-14 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −6 800 | 806 854 | −0,84 | 12,51 | −85 091 | 10 096 487 | |
2023-07-14 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −1 500 | 813 654 | −0,18 | 12,51 | −18 759 | 10 175 313 | |
2023-07-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −11 700 | 815 154 | −1,42 | 12,31 | −144 016 | 10 033 812 | |
2023-07-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 11 700 | 826 854 | 1,44 | 2,94 | 34 398 | 2 430 951 | |
2023-06-08 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −8 300 | 815 154 | −1,01 | 12,50 | −103 777 | 10 192 033 | |
2023-06-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −11 700 | 823 454 | −1,40 | 11,36 | −132 942 | 9 356 578 | |
2023-06-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 4 575 | 835 154 | 0,55 | 2,94 | 13 450 | 2 455 353 | |
2023-06-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 125 | 830 579 | 0,87 | 2,45 | 17 456 | 2 034 919 | |
2023-05-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −11 700 | 823 454 | −1,40 | 11,80 | −138 093 | 9 719 063 | |
2023-05-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 11 700 | 835 154 | 1,42 | 2,45 | 28 665 | 2 046 127 | |
2023-04-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | −11 700 | 823 454 | −1,40 | 11,21 | −131 207 | 9 234 460 | |
2023-04-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 11 700 | 835 154 | 1,42 | 2,45 | 28 665 | 2 046 127 | |
2023-03-17 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −13 375 | 823 454 | −1,60 | 11,43 | −152 876 | 9 412 079 | |
2023-03-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −4 544 | 836 829 | −0,54 | 13,68 | −62 146 | 11 444 976 |
2023-03-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −15 456 | 841 373 | −1,80 | 13,12 | −202 715 | 11 035 112 |
2023-03-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 11 700 | 856 829 | 1,38 | 2,45 | 28 665 | 2 099 231 | |
2023-02-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −20 000 | 845 129 | −2,31 | 12,98 | −259 508 | 10 965 887 |
2023-02-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 11 700 | 865 129 | 1,37 | 2,45 | 28 665 | 2 119 566 | |
2023-01-13 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −50 147 | 853 429 | −5,55 | 12,02 | −602 767 | 10 258 217 | |
2023-01-13 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 98 040 | 903 576 | 12,17 | ||||
2023-01-11 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −11 700 | 805 536 | −1,43 | 11,43 | −133 754 | 9 208 888 |
2023-01-11 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 11 700 | 817 236 | 1,45 | 2,45 | 28 665 | 2 002 228 | |
2023-01-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −7 094 | 805 536 | −0,87 | 12,03 | −85 341 | 9 690 598 | |
2023-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −19 048 | 812 630 | −2,29 | 11,93 | −227 243 | 9 694 676 | |
2023-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 169 635 | 831 678 | 25,62 | ||||
2023-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −27 575 | 662 043 | −4,00 | 12,21 | −336 691 | 8 083 545 | |
2022-12-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 485 | 689 618 | −0,79 | 12,20 | −66 926 | 8 414 443 |
2022-12-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 5 485 | 695 103 | 0,80 | 3,53 | 19 362 | 2 453 714 | |
2022-11-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 470 | 689 618 | −0,79 | 10,01 | −54 759 | 6 903 559 |
2022-11-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 5 470 | 695 088 | 0,79 | 3,53 | 19 309 | 2 453 661 | |
2022-10-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 470 | 689 618 | −0,79 | 10,53 | −57 624 | 7 264 850 |
2022-10-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 5 470 | 695 088 | 0,79 | 3,53 | 19 309 | 2 453 661 | |
2022-09-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 470 | 689 618 | −0,79 | 11,29 | −61 764 | 7 786 753 |
2022-09-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 5 470 | 695 088 | 0,79 | 3,53 | 19 309 | 2 453 661 | |
2022-08-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 470 | 689 618 | −0,79 | 10,03 | −54 883 | 6 919 213 |
2022-08-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 5 470 | 695 088 | 0,79 | 3,53 | 19 309 | 2 453 661 | |
2022-07-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 470 | 689 618 | −0,79 | 10,72 | −58 615 | 7 389 740 |
2022-07-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 5 470 | 695 088 | 0,79 | 3,53 | 19 309 | 2 453 661 | |
2022-06-22 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −16 410 | 689 618 | −2,32 | 10,00 | −164 100 | 6 896 180 |
2022-06-22 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 16 410 | 706 028 | 2,38 | 3,53 | 57 927 | 2 492 279 | |
2022-04-08 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
A - Award | 187 970 | 187 970 | |||||
2022-04-08 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 104 603 | 689 618 | 17,88 | ||||
2022-03-22 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 940 | 49 245 | −18,18 | ||||
2022-03-22 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 940 | 585 015 | −1,84 | 10,00 | −109 426 | 5 851 554 |
2022-03-22 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 940 | 595 955 | 1,87 | 3,53 | 38 618 | 2 103 721 | |
2022-01-19 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −32 386 | 585 015 | −5,25 | 10,53 | −341 025 | 6 160 208 | |
2022-01-19 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 63 317 | 617 401 | 11,43 | ||||
2022-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −7 368 | 554 084 | −1,31 | 12,48 | −91 953 | 6 914 968 | |
2022-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
A - Award | 283 555 | 283 555 | |||||
2022-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −5 470 | 60 185 | −8,33 | ||||
2022-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 154 711 | 561 452 | 38,04 | ||||
2022-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 470 | 406 741 | −1,33 | 11,86 | −64 880 | 4 824 396 |
2022-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 5 470 | 412 211 | 1,34 | 3,53 | 19 309 | 1 455 105 | |
2022-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −4 984 | 406 741 | −1,21 | 12,11 | −60 356 | 4 925 634 | |
2022-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −27 946 | 411 725 | −6,36 | 11,55 | −322 776 | 4 755 424 | |
2022-01-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −17 597 | 439 671 | −3,85 | 11,55 | −203 245 | 5 078 200 | |
2021-12-23 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −3 000 | 0 | −100,00 | ||||
2021-12-23 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −3 000 | 457 268 | −0,65 | 11,70 | −35 096 | 5 349 350 |
2021-12-23 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 3 000 | 460 268 | 0,66 | 4,38 | 13 140 | 2 015 974 | |
2021-12-02 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 515 | 3 000 | −77,80 | ||||
2021-12-02 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 515 | 457 268 | −2,25 | 11,00 | −115 706 | 5 031 731 |
2021-12-02 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 515 | 467 783 | 2,30 | 4,38 | 46 056 | 2 048 890 | |
2021-11-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 515 | 13 515 | −43,76 | ||||
2021-11-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 515 | 457 268 | −2,25 | 11,32 | −119 054 | 5 177 325 |
2021-11-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 515 | 467 783 | 2,30 | 4,38 | 46 056 | 2 048 890 | |
2021-10-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 515 | 24 030 | −30,44 | ||||
2021-10-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 515 | 457 268 | −2,25 | 10,00 | −105 150 | 4 572 680 |
2021-10-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 515 | 467 783 | 2,30 | 4,38 | 46 056 | 2 048 890 | |
2021-09-07 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 515 | 34 545 | −23,34 | ||||
2021-09-07 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 515 | 457 268 | −2,25 | 11,50 | −120 905 | 5 257 805 |
2021-09-07 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 515 | 467 783 | 2,30 | 4,38 | 46 056 | 2 048 890 | |
2021-08-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −21 028 | 45 060 | −31,82 | ||||
2021-08-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −21 028 | 457 268 | −4,40 | 10,02 | −210 671 | 4 581 185 |
2021-08-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 21 028 | 478 296 | 4,60 | 4,38 | 92 103 | 2 094 936 | |
2021-06-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −3 891 | 66 088 | −5,56 | ||||
2021-06-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −6 623 | 0 | −100,00 | ||||
2021-06-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −12 345 | 65 655 | −15,83 | ||||
2021-06-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 653 | 0 | −100,00 | ||||
2021-06-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −15 223 | 74 777 | −16,91 | ||||
2021-06-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −24 375 | 65 625 | −27,08 | ||||
2021-06-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 514 | 457 268 | −2,25 | 10,01 | −105 207 | 4 575 607 |
2021-06-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 3 891 | 467 782 | 0,84 | 4,38 | 17 043 | 2 048 885 | |
2021-06-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 6 623 | 463 891 | 1,45 | 6,45 | 42 718 | 2 992 097 | |
2021-06-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −17 350 | 457 268 | −3,66 | 10,08 | −174 888 | 4 609 261 | |
2021-06-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 12 345 | 474 618 | 2,67 | 3,53 | 43 578 | 1 675 402 | |
2021-06-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 653 | 462 273 | 2,36 | 2,52 | 26 846 | 1 164 928 | |
2021-06-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 15 223 | 451 620 | 3,49 | 2,94 | 44 756 | 1 327 763 | |
2021-06-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 24 375 | 436 397 | 5,92 | 2,45 | 59 719 | 1 069 173 | |
2021-05-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 514 | 6 623 | −61,35 | ||||
2021-05-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 514 | 412 022 | −2,49 | 10,27 | −107 970 | 4 231 136 |
2021-05-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 514 | 422 536 | 2,55 | 6,45 | 67 815 | 2 725 357 | |
2021-04-08 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 33 165 | 412 022 | 8,75 | ||||
2021-04-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 514 | 17 137 | −38,02 | ||||
2021-04-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 514 | 378 857 | −2,70 | 10,03 | −105 505 | 3 801 716 |
2021-04-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 514 | 389 371 | 2,78 | 6,45 | 67 815 | 2 511 443 | |
2021-03-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 514 | 27 651 | −27,55 | ||||
2021-03-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 514 | 378 857 | −2,70 | 11,84 | −124 516 | 4 486 766 |
2021-03-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 514 | 389 371 | 2,78 | 6,45 | 67 815 | 2 511 443 | |
2021-02-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 514 | 38 165 | −21,60 | ||||
2021-02-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 514 | 378 857 | −2,70 | 19,08 | −200 571 | 7 227 303 |
2021-02-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 514 | 389 371 | 2,78 | 6,45 | 67 815 | 2 511 443 | |
2021-01-20 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −14 463 | 378 857 | −3,68 | 21,84 | −315 800 | 8 272 343 | |
2021-01-20 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 29 367 | 393 320 | 8,07 | ||||
2021-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
A - Award | 92 792 | 92 792 | |||||
2021-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 514 | 48 679 | −17,76 | ||||
2021-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 57 620 | 363 953 | 18,81 | ||||
2021-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 514 | 306 333 | −3,32 | 22,17 | −233 125 | 6 792 260 |
2021-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 514 | 316 847 | 3,43 | 6,45 | 67 815 | 2 043 663 | |
2021-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −13 974 | 306 333 | −4,36 | 23,09 | −322 660 | 7 073 229 | |
2021-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −26 908 | 320 307 | −7,75 | 23,09 | −621 306 | 7 395 889 | |
2021-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −7 617 | 347 215 | −2,15 | 23,09 | −175 877 | 8 017 194 | |
2020-12-17 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 021 | 69 979 | −12,53 | ||||
2020-12-17 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 807 | 59 193 | −15,44 | ||||
2020-12-17 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −4 760 | 354 832 | −1,32 | 23,86 | −113 574 | 8 466 292 | |
2020-12-17 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 021 | 359 592 | 2,87 | 4,38 | 43 892 | 1 575 013 | |
2020-12-17 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 807 | 349 571 | 3,19 | 6,45 | 69 705 | 2 254 733 | |
2020-12-02 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −24 783 | 10 653 | −69,94 | ||||
2020-12-02 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −24 783 | 338 764 | −6,82 | 22,77 | −564 192 | 7 712 064 |
2020-12-02 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 24 783 | 363 547 | 7,32 | 2,52 | 62 453 | 916 138 | |
2020-11-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −24 782 | 35 436 | −41,15 | ||||
2020-11-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −24 782 | 338 764 | −6,82 | 17,87 | −442 792 | 6 052 866 |
2020-11-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 24 782 | 363 546 | 7,32 | 2,52 | 62 451 | 916 136 | |
2020-09-30 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −24 782 | 60 218 | −29,16 | ||||
2020-09-30 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −24 782 | 338 764 | −6,82 | 13,89 | −344 205 | 4 705 195 |
2020-09-30 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 24 782 | 363 546 | 7,32 | 2,52 | 62 451 | 916 136 | |
2020-08-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2020-08-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −10 000 | 338 764 | −2,87 | 14,78 | −147 779 | 5 006 221 |
2020-08-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 000 | 348 764 | 2,95 | 6,06 | 60 600 | 2 113 510 | |
2020-07-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −2 500 | 10 000 | −20,00 | ||||
2020-07-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 500 | 338 764 | −0,73 | 16,01 | −40 025 | 5 423 612 |
2020-07-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 2 500 | 341 264 | 0,74 | 6,06 | 15 150 | 2 068 060 | |
2020-07-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −12 500 | 12 500 | −50,00 | ||||
2020-07-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −12 500 | 338 764 | −3,56 | 15,47 | −193 384 | 5 240 916 |
2020-07-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 12 500 | 351 264 | 3,69 | 6,06 | 75 750 | 2 128 660 | |
2020-06-23 |
|
4 | PGNX |
PROGENICS PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −25 000 | 0 | −100,00 | ||||
2020-06-23 |
|
4 | PGNX |
PROGENICS PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −25 000 | 0 | −100,00 | ||||
2020-06-23 |
|
4 | PGNX |
PROGENICS PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −20 000 | 0 | −100,00 | ||||
2020-06-23 |
|
4 | PGNX |
PROGENICS PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −28 000 | 0 | −100,00 | ||||
2020-06-23 |
|
4 | PGNX |
PROGENICS PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −12 000 | 0 | −100,00 | ||||
2020-06-17 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −9 089 | 338 764 | −2,61 | 11,14 | −101 251 | 3 773 831 | |
2020-06-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −2 500 | 25 000 | −9,09 | ||||
2020-06-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 500 | 347 853 | −0,71 | 13,01 | −32 525 | 4 525 568 |
2020-06-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 2 500 | 350 353 | 0,72 | 6,06 | 15 150 | 2 123 139 | |
2020-06-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 000 | 27 500 | −26,67 | ||||
2020-06-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −17 502 | 347 853 | −4,79 | 12,66 | −221 495 | 4 402 219 |
2020-06-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 000 | 365 355 | 2,81 | 6,06 | 60 600 | 2 214 051 | |
2020-05-28 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −2 500 | 37 500 | −6,25 | ||||
2020-05-28 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 500 | 355 355 | −0,70 | 13,01 | −32 525 | 4 623 169 |
2020-05-28 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 2 500 | 357 855 | 0,70 | 6,06 | 15 150 | 2 168 601 | |
2020-05-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −10 000 | 40 000 | −20,00 | ||||
2020-05-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −17 503 | 355 355 | −4,69 | 11,33 | −198 239 | 4 024 751 |
2020-05-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 10 000 | 372 858 | 2,76 | 6,06 | 60 600 | 2 259 519 | |
2020-04-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −2 500 | 50 000 | −4,76 | ||||
2020-04-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 500 | 362 858 | −0,68 | 10,12 | −25 300 | 3 672 123 |
2020-04-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 2 500 | 365 358 | 0,69 | 6,06 | 15 150 | 2 214 069 | |
2020-04-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −7 500 | 52 500 | −12,50 | ||||
2020-04-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 14 847 | 362 858 | 4,27 | ||||
2020-04-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −15 003 | 348 011 | −4,13 | 9,09 | −136 310 | 3 161 854 |
2020-04-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 500 | 363 014 | 2,11 | 6,06 | 45 450 | 2 199 865 | |
2020-03-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −2 500 | 0 | −100,00 | ||||
2020-03-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 500 | 355 514 | −0,70 | 10,01 | −25 025 | 3 558 695 |
2020-03-09 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 2 500 | 358 014 | 0,70 | 5,96 | 14 900 | 2 133 763 | |
2020-03-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −7 500 | 2 500 | −75,00 | ||||
2020-03-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −15 003 | 355 514 | −4,05 | 9,09 | −136 445 | 3 233 222 |
2020-03-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 500 | 370 517 | 2,07 | 5,96 | 44 700 | 2 208 281 | |
2020-02-07 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −2 500 | 10 000 | −20,00 | ||||
2020-02-07 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 500 | 363 017 | −0,68 | 10,01 | −25 025 | 3 633 800 |
2020-02-07 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 2 500 | 365 517 | 0,69 | 5,96 | 14 900 | 2 178 481 | |
2020-02-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −7 500 | 12 500 | −37,50 | ||||
2020-02-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −15 003 | 363 017 | −3,97 | 8,91 | −133 626 | 3 233 247 |
2020-02-04 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 500 | 378 020 | 2,02 | 5,96 | 44 700 | 2 252 999 | |
2020-01-17 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −5 064 | 370 520 | −1,35 | 10,35 | −52 388 | 3 833 104 |
2020-01-14 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −29 492 | 375 584 | −7,28 | 9,46 | −278 994 | 3 553 025 | |
2020-01-14 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 59 881 | 405 076 | 17,35 | ||||
2020-01-10 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −2 500 | 20 000 | −11,11 | ||||
2020-01-10 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 500 | 345 195 | −0,72 | 10,01 | −25 025 | 3 455 402 |
2020-01-10 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 2 500 | 347 695 | 0,72 | 5,96 | 14 900 | 2 072 262 | |
2020-01-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −13 973 | 345 195 | −3,89 | 9,18 | −128 272 | 3 168 890 | |
2020-01-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −12 161 | 359 168 | −3,27 | 9,55 | −116 138 | 3 430 054 | |
2020-01-06 |
|
4/A | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −2 438 | 371 329 | −0,65 | 9,56 | −23 310 | 3 550 314 |
2020-01-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −7 500 | 22 500 | −25,00 | ||||
2020-01-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
A - Award | 188 257 | 188 257 | |||||
2020-01-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −7 500 | 359 140 | −2,05 | 9,61 | −72 039 | 3 449 612 |
2020-01-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 7 500 | 366 640 | 2,09 | 5,96 | 44 700 | 2 185 174 | |
2020-01-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −14 627 | 359 140 | −3,91 | 9,56 | −139 850 | 3 433 773 |
2020-01-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 119 780 | 373 767 | 47,16 | ||||
2020-01-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −15 556 | 253 987 | −5,77 | 9,74 | −151 515 | 2 473 833 | |
2019-07-15 |
|
4 | PGNX |
PROGENICS PHARMACEUTICALS INC
Non-Qualified Stock Option (Right to Buy) |
A - Award | 25 000 | 25 000 | |||||
2019-07-08 |
|
4 | PGNX |
PROGENICS PHARMACEUTICALS INC
Non-Qualified Stock Option (Right to Buy) |
M - Exercise | −12 000 | 0 | −100,00 | ||||
2019-07-08 |
|
4 | PGNX |
PROGENICS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 12 000 | 12 000 | 4,89 | 58 680 | 58 680 | ||
2019-04-15 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 30 183 | 269 543 | 12,61 | ||||
2019-01-24 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
M - Exercise | −36 000 | 0 | −100,00 | ||||
2019-01-24 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
S - Sale | X | −36 000 | 239 360 | −13,07 | 11,81 | −425 135 | 2 826 674 |
2019-01-24 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
M - Exercise | 36 000 | 275 360 | 15,04 | 10,36 | 372 960 | 2 852 730 | |
2019-01-10 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
F - Taxes | −13 518 | 239 360 | −5,35 | 10,33 | −139 641 | 2 472 589 | |
2019-01-10 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
A - Award | 151 515 | 151 515 | |||||
2019-01-10 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 98 778 | 252 878 | 64,10 | ||||
2018-06-14 |
|
4 | PGNX |
PROGENICS PHARMACEUTICALS INC
Non-Qualified Stock Option (Right to Buy) |
A - Award | 25 000 | 25 000 | |||||
2018-01-24 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
M - Exercise | −32 500 | 0 | −100,00 | ||||
2018-01-24 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common Stock |
S - Sale | X | −32 500 | 154 100 | −17,42 | 15,92 | −517 371 | 2 453 133 |
2018-01-24 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common Stock |
M - Exercise | 32 500 | 186 600 | 21,09 | 10,21 | 331 825 | 1 905 186 | |
2018-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
A - Award | 56 329 | 56 329 | |||||
2018-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common Stock |
F - Taxes | −9 345 | 154 100 | −5,72 | 15,67 | −146 436 | 2 414 747 | |
2018-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common Stock |
A - Award | 38 973 | 163 445 | 31,31 | ||||
2017-06-19 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common Stock |
F - Taxes | −3 003 | 124 472 | −2,36 | 8,79 | −26 396 | 1 094 109 | |
2017-06-15 |
|
4 | PGNX |
PROGENICS PHARMACEUTICALS INC
Non-Qualified Stock Option (Right to Buy) |
A - Award | 20 000 | 20 000 | |||||
2017-03-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common Stock |
S - Sale | X | −49 050 | 127 475 | −27,79 | 8,00 | −392 400 | 1 019 800 |
2017-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Restricted Stock Units |
M - Exercise | −100 000 | 0 | −100,00 | ||||
2017-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
A - Award | 103 578 | 103 578 | |||||
2017-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common Stock |
F - Taxes | −50 950 | 176 525 | −22,40 | 5,13 | −261 374 | 905 573 | |
2017-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common Stock |
M - Exercise | 100 000 | 227 475 | 78,45 | ||||
2017-01-05 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common Stock |
A - Award | 74 525 | 127 475 | 140,75 | ||||
2016-06-17 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
A - Award | 75 000 | 75 000 | |||||
2016-06-17 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common Stock |
A - Award | 25 000 | 52 950 | 89,45 | ||||
2016-06-09 |
|
4 | PGNX |
PROGENICS PHARMACEUTICALS INC
Non-Qualified Stock Option (Right to Buy) |
A - Award | 40 000 | 40 000 | |||||
2016-01-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
A - Award | 100 000 | 100 000 | |||||
2016-01-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Restricted stock units |
M - Exercise | −50 000 | 100 000 | −33,33 | ||||
2016-01-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
F - Taxes | −18 625 | 37 950 | −32,92 | 9,03 | −168 184 | 342 688 | |
2016-01-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
M - Exercise | 50 000 | 56 575 | 760,46 | ||||
2015-09-22 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stocl Options (right to buy) |
M - Exercise | X | −417 | 0 | −100,00 | |||
2015-09-22 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
M - Exercise | X | −12 584 | 0 | −100,00 | |||
2015-09-22 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
S - Sale | X | −13 001 | 156 575 | −7,67 | 16,78 | −218 206 | 2 627 923 |
2015-09-22 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
M - Exercise | X | 13 001 | 169 576 | 8,30 | 16,78 | 218 206 | 2 846 130 |
2015-06-23 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stocl Options (right to buy) |
M - Exercise | −416 | 19 167 | −2,12 | ||||
2015-06-23 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
M - Exercise | X | −12 583 | 12 584 | −50,00 | |||
2015-06-23 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
S - Sale | X | −13 000 | 156 575 | −7,67 | 13,26 | −172 424 | 2 076 717 |
2015-06-23 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
M - Exercise | X | 417 | 169 575 | 0,25 | 13,26 | 5 531 | 2 249 141 |
2015-06-23 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
M - Exercise | X | 12 583 | 169 158 | 8,04 | 13,26 | 166 893 | 2 243 610 |
2015-06-03 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
A - Award | 100 000 | 100 000 | |||||
2015-05-12 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
S - Sale | X | −24 800 | 6 575 | −79,04 | 10,84 | −268 810 | 71 267 |
2015-05-12 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Restricted stock units |
M - Exercise | −50 000 | 150 000 | −25,00 | ||||
2015-05-12 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
F - Taxes | −18 625 | 31 375 | −37,25 | 10,80 | −201 150 | 338 850 | |
2015-05-12 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
M - Exercise | 50 000 | 50 000 | |||||
2015-03-24 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stocl Options (right to buy) |
M - Exercise | X | −416 | 19 584 | −2,08 | |||
2015-03-24 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
M - Exercise | X | −12 583 | 25 167 | −33,33 | |||
2015-03-24 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
S - Sale | X | −12 999 | 200 000 | −6,10 | 11,51 | −149 595 | 2 301 640 |
2015-03-24 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
M - Exercise | X | 416 | 212 999 | 0,20 | 11,51 | 4 787 | 2 451 235 |
2015-03-24 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
M - Exercise | X | 12 583 | 212 583 | 6,29 | 11,51 | 144 808 | 2 446 448 |
2015-01-30 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
A - Award | 90 000 | 90 000 | |||||
2014-11-25 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
M - Exercise | X | −7 250 | 37 750 | −16,11 | |||
2014-11-25 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
S - Sale | X | −7 250 | 200 000 | −3,50 | 8,00 | −58 000 | 1 600 000 |
2014-11-25 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
P - Purchase | X | 7 250 | 207 250 | 3,62 | 8,00 | 58 000 | 1 658 000 |
2014-08-26 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
M - Exercise | X | −7 000 | 78 000 | −8,24 | |||
2014-08-26 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
S - Sale | X | −7 000 | 200 000 | −3,38 | 6,00 | −42 000 | 1 200 000 |
2014-08-26 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
P - Purchase | X | 7 000 | 207 000 | 3,50 | 6,00 | 42 000 | 1 242 000 |
2014-08-21 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
M - Exercise | X | −18 750 | 1 250 | −93,75 | |||
2014-08-21 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
S - Sale | X | −18 750 | 200 000 | −8,57 | 5,40 | −101 250 | 1 080 000 |
2014-08-21 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
P - Purchase | X | 18 750 | 218 750 | 9,38 | 5,40 | 101 250 | 1 181 250 |
2014-06-30 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
A - Award | 90 000 | 90 000 | |||||
2014-06-30 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
A - Award | 100 000 | 200 000 | 100,00 | ||||
2014-04-11 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common stock |
A - Award | 100 000 | 100 000 | |||||
2014-01-07 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
A - Award | 90 000 | 90 000 | |||||
2013-06-20 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
A - Award | 85 000 | 85 000 | |||||
2013-01-30 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
A - Award | 85 000 | 85 000 | |||||
2012-06-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
A - Award | 80 000 | 80 000 | |||||
2012-02-17 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Options (right to buy) |
A - Award | 70 000 | 70 000 |